REAPTAN 10/10 perindopril arginine 10mg/ amlodipine (as besilate) 10mg tablet bottle Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

reaptan 10/10 perindopril arginine 10mg/ amlodipine (as besilate) 10mg tablet bottle

servier laboratories (aust) pty ltd - perindopril arginine, quantity: 10 mg; amlodipine besilate, quantity: 13.87 mg - tablet, uncoated - excipient ingredients: magnesium stearate; colloidal anhydrous silica; lactose monohydrate; microcrystalline cellulose - is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

REAPTAN 10/5 perindopril arginine 10mg/ amlodipine (as besilate) 5mg tablet bottle Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

reaptan 10/5 perindopril arginine 10mg/ amlodipine (as besilate) 5mg tablet bottle

servier laboratories (aust) pty ltd - amlodipine besilate, quantity: 6.935 mg; perindopril arginine, quantity: 10 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; magnesium stearate; lactose monohydrate; microcrystalline cellulose - is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

REAPTAN 5/10 perindopril arginine 5mg/ amlodipine (as besilate) 10mg tablet bottl Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

reaptan 5/10 perindopril arginine 5mg/ amlodipine (as besilate) 10mg tablet bottl

servier laboratories (aust) pty ltd - amlodipine besilate, quantity: 13.87 mg; perindopril arginine, quantity: 5 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; magnesium stearate; lactose monohydrate; microcrystalline cellulose - is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

REAPTAN 5/5 perindopril arginine 5mg/ amlodipine (as besilate) 5mg tablet bottle Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

reaptan 5/5 perindopril arginine 5mg/ amlodipine (as besilate) 5mg tablet bottle

servier laboratories (aust) pty ltd - amlodipine besilate, quantity: 6.935 mg; perindopril arginine, quantity: 5 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; magnesium stearate; lactose monohydrate; colloidal anhydrous silica - is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

COVERAM 10/10 perindopril arginine 10mg/ amlodipine (as besilate) 10mg uncoated tablet bottle Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

coveram 10/10 perindopril arginine 10mg/ amlodipine (as besilate) 10mg uncoated tablet bottle

servier laboratories (aust) pty ltd - amlodipine besilate, quantity: 13.87 mg; perindopril arginine, quantity: 10 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; microcrystalline cellulose; lactose monohydrate; magnesium stearate - coveram is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

COVERAM 10/5 perindopril arginine 10mg/ amlodipine (as besilate) 5mg uncoated tablet bottle Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

coveram 10/5 perindopril arginine 10mg/ amlodipine (as besilate) 5mg uncoated tablet bottle

servier laboratories (aust) pty ltd - perindopril arginine, quantity: 10 mg; amlodipine besilate, quantity: 6.935 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; magnesium stearate; colloidal anhydrous silica - coveram is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

COVERAM 5/10 perindopril arginine 5mg/ amlodipine (as besilate) 10mg uncoated tablet bottle Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

coveram 5/10 perindopril arginine 5mg/ amlodipine (as besilate) 10mg uncoated tablet bottle

servier laboratories (aust) pty ltd - amlodipine besilate, quantity: 13.87 mg; perindopril arginine, quantity: 5 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; lactose monohydrate - coveram is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

COVERAM 5/5 perindopril arginine 5mg/ amlodipine (as besilate) 5mg uncoated tablet bottle Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

coveram 5/5 perindopril arginine 5mg/ amlodipine (as besilate) 5mg uncoated tablet bottle

servier laboratories (aust) pty ltd - amlodipine besilate, quantity: 6.935 mg; perindopril arginine, quantity: 5 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; magnesium stearate; colloidal anhydrous silica - coveram is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

CHEMMART Perindopril Arginine/Amlodipine 10/5 perindopril arginine 10 mg and amlodipine (as besilate) 5 mg uncoated tablet bottle Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

chemmart perindopril arginine/amlodipine 10/5 perindopril arginine 10 mg and amlodipine (as besilate) 5 mg uncoated tablet bottle

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg); perindopril arginine, quantity: 10 mg - tablet - excipient ingredients: croscarmellose sodium; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

GenRx Perindopril Arginine/Amlodipine 5/10 perindopril arginine 5 mg and amlodipine (as besilate) 10 mg uncoated tablet blister pack Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

genrx perindopril arginine/amlodipine 5/10 perindopril arginine 5 mg and amlodipine (as besilate) 10 mg uncoated tablet blister pack

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg); perindopril arginine, quantity: 5 mg - tablet - excipient ingredients: colloidal anhydrous silica; magnesium stearate; croscarmellose sodium; microcrystalline cellulose - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.